Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 310

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 310
---
 $ | 30.4 | ​ | ​ |
| Less: Operating Expenses during Liquidation Period       | ​ | ​ | ​ | $ | -0.3 | ​ | ​ |
| 3/31/25 Ending Cash, Net Future Operating Costs          | ​ | ​ | ​ | $ | 30.1 | ​ | ​ |
| Less: Expected Final Distribution                        | ​ | ​ | ​ | $ | -0.5 | ​ | ​ |
| Initial Distribution (3/31/2025)                         | ​ | ​ | ​ | $ | 29.6 | ​ | ​ |
| Diluted Shares Outstanding (Using treasury stock method) | ​ | ​ | ​ | ​ | 55.8 | ​ | ​ |
| Undiscounted Initial Distribution Per Share (3/31/25)    | ​ | ​ | ​ | $ | 0.53 | ​ | ​ |
| Discounted Initial Distribution (Aggregate)              | ​ | ​ | ​ | $ | 29.1 | ​ | ​ |
| Discounted Initial Distribution (Per Share)              | ​ | ​ | ​ | $ | 0.52 | ​ | ​ |
| 3/31/25 Ending Cash, Net Initial Distribution            | ​ | ​ | ​ | $ |  0.8 | ​ | ​ |
| Less: Operating Expenses during Liquidation Period       | ​ | ​ | ​ | $ | -0.3 | ​ | ​ |
| Cash Available to Distribute (3/31/2028)                 | ​ | ​ | ​ | $ |  0.5 | ​ | ​ |
| Diluted Shares Outstanding (Using Treasury Stock Method) | ​ | ​ | ​ | ​ | 55.8 | ​ | ​ |
| Undiscounted Final Distribution Per Share (3/31/2028)    | ​ | ​ | ​ | $ | 0.01 | ​ | ​ |
| Discounted Final Distribution (Aggregate)                | ​ | ​ | ​ | $ |  0.4 | ​ | ​ |
| Discounted Final Distribution (Per Share)                | ​ | ​ | ​ | $ | 0.01 | ​ | ​ |
| Total Present Value of Distributions (Aggregate)         | ​ | ​ | ​ | $ | 29.6 | ​ | ​ |
| Total Present Value of Distribution (Per Share)          | ​ | ​ | ​ | $ |